Citizens JMP raised the firm’s price target on American Healthcare REIT (AHR) to $60 from $50 and keeps an Outperform rating on the shares following the Q3 earnings report. The combination of internal and external activities has allowed American Healthcare REIT to generate the highest FFO growth rate in the Healthcare REIT industry, and with 70% exposure to RIDEA assets, American Healthcare is uniquely positioned to capitalize on ideal supply/demand fundamentals for senior housing, the analyst tells investors in a research note. The firm recommends the stock as its top idea.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT Reports Robust Earnings Growth
- American Healthcare REIT, Inc. Reports Strong Q3 2025 Results
- American Healthcare REIT Reports Strong Q3 2025 Results
- American Healthcare REIT reports Q3 normalized FFO 44c, consensus 42c
- American Healthcare REIT raises2025 NFFO view to $1.69-$1.72 from $1.64-$1.68